APA (7th ed.) Citation

Z, L., X, L., Y, G., G, S., & Y, Z. (2026). Characteristics of adverse events and clinical risks of intravenous immunoglobulin: A pharmacovigilance study based on FDA Adverse Event Reporting System (FAERS). Frontiers in medicine, 12, 1724196. https://doi.org/10.3389/fmed.2025.1724196

Chicago Style (17th ed.) Citation

Z, Lu, Lu X, Gao Y, Shang G, and Zeng Y. "Characteristics of Adverse Events and Clinical Risks of Intravenous Immunoglobulin: A Pharmacovigilance Study Based on FDA Adverse Event Reporting System (FAERS)." Frontiers in Medicine 12 (2026): 1724196. https://doi.org/10.3389/fmed.2025.1724196.

MLA (9th ed.) Citation

Z, Lu, et al. "Characteristics of Adverse Events and Clinical Risks of Intravenous Immunoglobulin: A Pharmacovigilance Study Based on FDA Adverse Event Reporting System (FAERS)." Frontiers in Medicine, vol. 12, 2026, p. 1724196, https://doi.org/10.3389/fmed.2025.1724196.